Data from: Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study

 

Files in this package

Content in the Dryad Digital Repository is offered "as is." By downloading files, you agree to the Dryad Terms of Service. To the extent possible under law, the authors have waived all copyright and related or neighboring rights to this data. CC0 (opens a new window) Open Data (opens a new window)

Title Main table - NAS database
Downloaded 127 times
Description Database listing all new active substances approved by Health Canada from January 1, 1995 to March 31, 2013 along with dates and nature of serious safety warnings (dates in bold)
Download Main table - NAS database.xlsx (94.72 Kb)
Details View File Details
Title Therapeutic rating scores
Downloaded 92 times
Description Database contains the therapeutic rating scores for new active substances from the Patented Medicine Prices Review Board and from Prescrire International.
Download NAS - PMPRB & Prescrire ratings.xlsx (980.7 Kb)
Details View File Details

When using this data, please cite the original publication:

Lexchin J (2014) Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study. BMJ Open 4(2): e004289. http://dx.doi.org/10.1136/bmjopen-2013-004289

Additionally, please cite the Dryad data package:

Lexchin J (2014) Data from: Postmarket safety in Canada: are significant therapeutic advances and biologics less safe than other drugs? A cohort study. Dryad Digital Repository. http://dx.doi.org/10.5061/dryad.fg679
Cite | Share
Download the data package citation in the following formats:
   RIS (compatible with EndNote, Reference Manager, ProCite, RefWorks)
   BibTex (compatible with BibDesk, LaTeX)

Search for data

Be part of Dryad

We encourage organizations to: